SENSEI BIOTHERAPEUTICS INC (SNSE) Forecast, Price Target & Analyst Ratings

NASDAQ:SNSE • US81728A2078

Current stock price

29.97 USD
-2.81 (-8.57%)
At close:
31 USD
+1.03 (+3.44%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SENSEI BIOTHERAPEUTICS INC (SNSE).

Forecast Snapshot

Consensus Price Target

Price Target
$33.15
+ 10.61% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 26, 2026
Period
Q4 / 2025
EPS Estimate
-$4.91
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$33.15
Upside
+ 10.61%
From current price of $29.97 to mean target of $33.15, Based on 6 analyst forecasts
Low
$30.30
Median
$33.15
High
$36.75

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for SNSE. The average price target is 33.15 USD. This implies a price increase of 10.61% is expected in the next year compared to the current price of 29.97.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SNSE Current Analyst RatingSNSE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

SNSE Historical Analyst RatingsSNSE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
SNSE was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about SNSE.
In the previous month the buy percentage consensus was at a similar level.
SNSE was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-10-30HC Wainwright & Co.Downgrade Buy -> Neutral
2025-08-05HC Wainwright & Co.Maintains Buy -> Buy
2025-03-28OppenheimerMaintains Outperform -> Outperform
2025-03-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-08HC Wainwright & Co.Maintains Buy -> Buy
2024-08-07HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-03CitigroupReiterate Buy -> Buy
2024-05-24Stephens & Co.Reiterate Overweight -> Overweight
2024-05-24HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-14Stephens & Co.Initiate Overweight
2023-12-04HC Wainwright & Co.Initiate Buy
2022-12-13CitigroupInitiate Buy
2022-10-03OppenheimerUpgrade Perform -> Outperform
2022-03-10Piper SandlerMaintains Overweight
2021-07-01BerenbergDowngrade Buy -> Hold
2021-06-29OppenheimerDowngrade Outperform -> Perform
2021-03-01OppenheimerInitiate Outperform
2021-03-01Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 26, 2026
Period
Q4 / 2025
EPS Estimate
-$4.91
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
20.87%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

SNSE is expected to report earnings on 3/26/2026. The consensus EPS estimate for the next earnings is -4.91 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
SNSE revenue by date.SNSE revenue by date.
N/AN/AN/AN/AN/AN/A
270.65%		N/A
126.82%		N/A
75.09%
EBITDA
YoY % growth
SNSE ebitda by date.SNSE ebitda by date.
-12.7M-12.36M
2.68%		-18.51M
-49.76%		-36.8M
-98.81%		-48.84M
-32.72%		-35.713M
26.88%		-30.341M
15.04%		N/A
16.63%		N/A
-17.34%		N/A
-10.31%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
SNSE ebit by date.SNSE ebit by date.
-12.74M-12.43M
2.43%		-18.72M
-50.60%		-37.49M
-100.27%		-50.19M
-33.88%		-37.064M
26.15%		-31.663M
14.57%		N/A
20.11%		N/A
-17.34%		N/A
-10.31%		N/A
-35.26%		N/A
-5.71%		N/A
17.54%		N/A
56.44%		N/A
392.59%
Operating Margin
SNSE operating margin by date.SNSE operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
SNSE eps by date.SNSE eps by date.
N/AN/AN/A-27.20
71.39%		-31.60
-16.18%		-24.40
22.78%		-24.00
1.64%		N/A
22.78%		N/A
17.17%		N/A
17.41%		N/A
-15.85%		N/A
17.36%		N/A
33.11%		N/A
63.19%		N/A
478.84%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25
EPS
Q2Q % growth		-4.91
20.87%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-6.834M
-13.88%
EBIT
Q2Q % growth		-4.692M
35.93%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SNSE Yearly Revenue VS EstimatesSNSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 50M 100M 150M
SNSE Yearly EPS VS EstimatesSNSE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -20 -40 -60 -80

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
13.75%
EPS Next 5 Year
8.36%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
0.09%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SENSEI BIOTHERAPEUTICS INC / SNSE Forecast FAQ

What do analysts expect the price target to be for SENSEI BIOTHERAPEUTICS INC (SNSE)?

6 analysts have analysed SNSE and the average price target is 33.15 USD. This implies a price increase of 10.61% is expected in the next year compared to the current price of 29.97.

When does SENSEI BIOTHERAPEUTICS INC (SNSE) report earnings?

SENSEI BIOTHERAPEUTICS INC (SNSE) will report earnings on 2026-03-26, after the market close.

What are the consensus estimates for SENSEI BIOTHERAPEUTICS INC (SNSE) next earnings?

The consensus EPS estimate for the next earnings of SENSEI BIOTHERAPEUTICS INC (SNSE) is -4.91 USD and the consensus revenue estimate is 0 USD.

How many analysts cover SENSEI BIOTHERAPEUTICS INC (SNSE) stock?

The number of analysts covering SENSEI BIOTHERAPEUTICS INC (SNSE) is 6.